Your browser doesn't support javascript.
loading
Optimizing MR-Guided Radiotherapy for Breast Cancer Patients.
Groot Koerkamp, Maureen L; Vasmel, Jeanine E; Russell, Nicola S; Shaitelman, Simona F; Anandadas, Carmel N; Currey, Adam; Vesprini, Danny; Keller, Brian M; De-Colle, Chiara; Han, Kathy; Braunstein, Lior Z; Mahmood, Faisal; Lorenzen, Ebbe L; Philippens, Marielle E P; Verkooijen, Helena M; Lagendijk, Jan J W; Houweling, Antonetta C; van den Bongard, H J G Desiree; Kirby, Anna M.
Afiliación
  • Groot Koerkamp ML; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Vasmel JE; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Russell NS; Department of Radiotherapy, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
  • Shaitelman SF; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Anandadas CN; Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Currey A; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
  • Vesprini D; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Keller BM; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • De-Colle C; Department of Radiation Oncology, University Hospital and Medical Faculty, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Han K; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Braunstein LZ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Mahmood F; Department of Oncology, Odense University Hospital, Odense, Denmark.
  • Lorenzen EL; Research Unit for Oncology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Philippens MEP; Department of Oncology, Odense University Hospital, Odense, Denmark.
  • Verkooijen HM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Lagendijk JJW; Imaging Division, University Medical Center Utrecht, Utrecht, Netherlands.
  • Houweling AC; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
  • van den Bongard HJGD; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Kirby AM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
Front Oncol ; 10: 1107, 2020.
Article en En | MEDLINE | ID: mdl-32850318
ABSTRACT
Current research in radiotherapy (RT) for breast cancer is evaluating neoadjuvant as opposed to adjuvant partial breast irradiation (PBI) with the aim of reducing the volume of breast tissue irradiated and therefore the risk of late treatment-related toxicity. The development of magnetic resonance (MR)-guided RT, including dedicated MR-guided RT systems [hybrid machines combining an MR scanner with a linear accelerator (MR-linac) or 60Co sources], could potentially reduce the irradiated volume even further by improving tumour visibility before and during each RT treatment. In this position paper, we discuss MR guidance in relation to each step of the breast RT planning and treatment pathway, focusing on the application of MR-guided RT to neoadjuvant PBI.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos